Cedar Rapids Gazette: Iowa hospitals report they’re having no problems getting enough doses of the injections that prevent people from developing severe illness from COVID-19. About a month ago, federal officials started a new distribution system for the doses, putting states in charge of distributing the monoclonal antibody treatments. “The research is showing that it is really helping prevent the patient from developing severe disease,” said Dr. Rami Boutros, a pediatrician and executive medical director for University of Iowa Health Care-Iowa River Landing. The treatments provide antibodies to fight COVID-19 in people who’ve been exposed to or diagnosed with the virus.  The treatments — approved by the U.S. Food and Drug Administration under an emergency use authorization — trigger an immune response to infection that prevents severe illness, hospitalization and death.